Differential effects of dietary supplements on metabolomic profile of smokers versus non-smokers.

Abstract:

BACKGROUND:Cigarette smoking is well-known to associate with accelerated skin aging as well as cardiovascular disease and lung cancer, in large part due to oxidative stress. Because metabolites are downstream of genetic variation, as well as transcriptional changes and post-translational modifications of proteins, they are the most proximal reporters of disease states or reversal of disease states. METHODS:In this study, we explore the potential effects of commonly available oral supplements (containing antioxidants, vitamins and omega-3 fatty acids) on the metabolomes of smokers (n = 11) compared to non-smokers (n = 17). At baseline and after 12 weeks of supplementation, metabolomic analysis was performed on serum by liquid and gas chromatography with mass spectroscopy (LC-MS and GC-MS). Furthermore, clinical parameters of skin aging, including cutometry as assessed by three dermatologist raters blinded to subjects' age and smoking status, were measured. RESULTS:Long-chain fatty acids, including palmitate and oleate, decreased in smokers by 0.76-fold (P = 0.0045) and 0.72-fold (P = 0.0112), respectively. These changes were not observed in non-smokers. Furthermore, age and smoking status showed increased glow (P = 0.004) and a decrease in fine wrinkling (P = 0.038). Cutometry showed an increase in skin elasticity in smokers (P = 0.049) but not in non-smokers. Complexion analysis software (VISIA) revealed decreases in the number of ultraviolet spots (P = 0.031), and cutometry showed increased elasticity (P = 0.05) in smokers but not non-smokers. CONCLUSIONS:Additional future work may shed light on the specific mechanisms by which long-chain fatty acids can lead to increased glow, improved elasticity measures and decreased fine wrinkling in smokers' skin. Our study provides a novel, medicine-focused application of available metabolomic technology to identify changes in sera of human subjects with oxidative stress, and suggests that oral supplementation (in particular, commonly available antioxidants, vitamins and omega-3 fatty acids) affects these individuals in a way that is unique (compared to non-smokers) on a broad level.

journal_name

Genome Med

journal_title

Genome medicine

authors

Spitale RC,Cheng MY,Chun KA,Gorell ES,Munoz CA,Kern DG,Wood SM,Knaggs HE,Wulff J,Beebe KD,Chang AL

doi

10.1186/gm313

subject

Has Abstract

pub_date

2012-02-23 00:00:00

pages

14

issue

2

issn

1756-994X

pii

gm313

journal_volume

4

pub_type

杂志文章
  • Creating a data resource: what will it take to build a medical information commons?

    abstract::National and international public-private partnerships, consortia, and government initiatives are underway to collect and share genomic, personal, and healthcare data on a massive scale. Ideally, these efforts will contribute to the creation of a medical information commons (MIC), a comprehensive data resource that is...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0476-3

    authors: Deverka PA,Majumder MA,Villanueva AG,Anderson M,Bakker AC,Bardill J,Boerwinkle E,Bubela T,Evans BJ,Garrison NA,Gibbs RA,Gentleman R,Glazer D,Goldstein MM,Greely H,Harris C,Knoppers BM,Koenig BA,Kohane IS,La Rosa S,

    更新日期:2017-09-22 00:00:00

  • Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles.

    abstract:BACKGROUND:The apolipoprotein E (APOE) ε4 allele is the strongest genetic risk factor for late onset Alzheimer's disease, whilst the ε2 allele confers protection. Previous studies report differential DNA methylation of APOE between ε4 and ε2 carriers, but associations with epigenome-wide methylation have not previously...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00808-4

    authors: Walker RM,Vaher K,Bermingham ML,Morris SW,Bretherick AD,Zeng Y,Rawlik K,Amador C,Campbell A,Haley CS,Hayward C,Porteous DJ,McIntosh AM,Marioni RE,Evans KL

    更新日期:2021-01-04 00:00:00

  • Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering.

    abstract:BACKGROUND:Comprehensive molecular profiling has revealed somatic variations in cancer at genomic, epigenomic, transcriptomic, and proteomic levels. The accumulating data has shown clearly that molecular phenotypes of cancer are complex and influenced by a multitude of factors. Conventional unsupervised clustering appl...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00804-8

    authors: Arora A,Olshen AB,Seshan VE,Shen R

    更新日期:2020-12-03 00:00:00

  • Wnt-regulated lncRNA discovery enhanced by in vivo identification and CRISPRi functional validation.

    abstract:BACKGROUND:Wnt signaling is an evolutionarily conserved developmental pathway that is frequently hyperactivated in cancer. While multiple protein-coding genes regulated by Wnt signaling are known, the functional lncRNAs regulated by Wnt signaling have not been systematically characterized. METHODS:We comprehensively m...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00788-5

    authors: Liu S,Harmston N,Glaser TL,Wong Y,Zhong Z,Madan B,Virshup DM,Petretto E

    更新日期:2020-10-22 00:00:00

  • Genome-wide association studies are coming for human infectious diseases.

    abstract::A genetic contribution to infectious disease in human populations has long been suspected and is now supported by more than 50 years of epidemiological evidence showing, for example, infection rates to be much higher than disease rates. In successful family studies of high-penetrance effects, single gene mutations hav...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm19

    authors: Davila S,Hibberd ML

    更新日期:2009-02-10 00:00:00

  • DawnRank: discovering personalized driver genes in cancer.

    abstract::Large-scale cancer genomic studies have revealed that the genetic heterogeneity of the same type of cancer is greater than previously thought. A key question in cancer genomics is the identification of driver genes. Although existing methods have identified many common drivers, it remains challenging to predict person...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-014-0056-8

    authors: Hou JP,Ma J

    更新日期:2014-07-31 00:00:00

  • Sharing knowledge: a new frontier for public-private partnerships in medicine.

    abstract::To help overcome the bottlenecks that limit the development of diagnostic and therapeutic products, academic and industrial researchers, patient organizations and charities, and regulatory and funding institutions should redefine the basis for sharing the knowledge collected in large-scale clinical and experimental st...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm29

    authors: Auffray C

    更新日期:2009-03-04 00:00:00

  • Genome-wide approaches for identifying genetic risk factors for osteoporosis.

    abstract::Osteoporosis, the most common type of bone disease worldwide, is clinically characterized by low bone mineral density (BMD) and increased susceptibility to fracture. Multiple genetic and environmental factors and gene-environment interactions have been implicated in its pathogenesis. Osteoporosis has strong genetic de...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/gm448

    authors: Wu S,Liu Y,Zhang L,Han Y,Lin Y,Deng HW

    更新日期:2013-05-29 00:00:00

  • Systems and genome-wide approaches unite to provide a route to personalized medicine.

    abstract::A report on the Keystone Symposium 'Complex Traits: Genomics and Computational approaches', Breckenridge, Colorado, USA, 20-25 February 2012. ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm328

    authors: Stranger BE,Björkegren J,Dolan ME,Ritchie MD

    更新日期:2012-03-30 00:00:00

  • Clinical laboratory test-wide association scan of polygenic scores identifies biomarkers of complex disease.

    abstract:BACKGROUND:Clinical laboratory (lab) tests are used in clinical practice to diagnose, treat, and monitor disease conditions. Test results are stored in electronic health records (EHRs), and a growing number of EHRs are linked to patient DNA, offering unprecedented opportunities to query relationships between genetic ri...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00820-8

    authors: Dennis JK,Sealock JM,Straub P,Lee YH,Hucks D,Actkins K,Faucon A,Feng YA,Ge T,Goleva SB,Niarchou M,Singh K,Morley T,Smoller JW,Ruderfer DM,Mosley JD,Chen G,Davis LK

    更新日期:2021-01-13 00:00:00

  • Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment.

    abstract:BACKGROUND:The human gut microbiome is associated with the development of colon cancer, and recent studies have found changes in the microbiome in cancer patients compared to healthy controls. Studying the microbial communities in the tumor microenvironment may shed light on the role of host-bacteria interactions in co...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0177-8

    authors: Burns MB,Lynch J,Starr TK,Knights D,Blekhman R

    更新日期:2015-06-24 00:00:00

  • Host genetic variation and its microbiome interactions within the Human Microbiome Project.

    abstract:BACKGROUND:Despite the increasing recognition that microbial communities within the human body are linked to health, we have an incomplete understanding of the environmental and molecular interactions that shape the composition of these communities. Although host genetic factors play a role in these interactions, these...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0515-8

    authors: Kolde R,Franzosa EA,Rahnavard G,Hall AB,Vlamakis H,Stevens C,Daly MJ,Xavier RJ,Huttenhower C

    更新日期:2018-01-29 00:00:00

  • Optimizing the treatment of BRAF mutant melanoma.

    abstract::Selective inhibitors of the kinases BRAF and MEK for the treatment of patients with otherwise refractory BRAF mutant melanoma have demonstrated impressive efficacy, and combination treatment with these agents may prove to be even more effective. However, these drugs are not curative, mainly because of the relatively r...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm547

    authors: Settleman J

    更新日期:2014-04-28 00:00:00

  • Cord blood DNA methylome in newborns later diagnosed with autism spectrum disorder reflects early dysregulation of neurodevelopmental and X-linked genes.

    abstract:BACKGROUND:Autism spectrum disorder (ASD) is a neurodevelopmental disorder with complex heritability and higher prevalence in males. The neonatal epigenome has the potential to reflect past interactions between genetic and environmental factors during early development and influence future health outcomes. METHODS:We ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00785-8

    authors: Mordaunt CE,Jianu JM,Laufer BI,Zhu Y,Hwang H,Dunaway KW,Bakulski KM,Feinberg JI,Volk HE,Lyall K,Croen LA,Newschaffer CJ,Ozonoff S,Hertz-Picciotto I,Fallin MD,Schmidt RJ,LaSalle JM

    更新日期:2020-10-14 00:00:00

  • The Human Gene Mutation Database: 2008 update.

    abstract::The Human Gene Mutation Database (HGMD((R))) is a comprehensive core collection of germline mutations in nuclear genes that underlie or are associated with human inherited disease. Here, we summarize the history of the database and its current resources. By December 2008, the database contained over 85,000 different l...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm13

    authors: Stenson PD,Mort M,Ball EV,Howells K,Phillips AD,Thomas NS,Cooper DN

    更新日期:2009-01-22 00:00:00

  • Prenatal diagnosis of fetal aneuploidies: post-genomic developments.

    abstract::Prenatal diagnosis of fetal aneuploidies and chromosomal anomalies is likely to undergo a profound change in the near future. On the one hand this is mediated by new technical developments, such as chromosomal microarrays, which allow a much more precise delineation of minute sub-microscopic chromosomal aberrancies th...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm171

    authors: Hahn S,Jackson LG,Zimmermann BG

    更新日期:2010-08-05 00:00:00

  • Pancreatic cancer genomics: insights and opportunities for clinical translation.

    abstract::Pancreatic cancer is a highly lethal tumor type for which there are few viable therapeutic options. It is also caused by the accumulation of mutations in a variety of genes. These genetic alterations can be grouped into those that accumulate during pancreatic intraepithelial neoplasia (precursor lesions) and thus are ...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/gm430

    authors: Makohon-Moore A,Brosnan JA,Iacobuzio-Donahue CA

    更新日期:2013-03-28 00:00:00

  • Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci.

    abstract:BACKGROUND:Systemic sclerosis (SSc) is a genetically complex autoimmune disease mediated by the interplay between genetic and epigenetic factors in a multitude of immune cells, with CD4+ T lymphocytes as one of the principle drivers of pathogenesis. METHODS:DNA samples exacted from CD4+ T cells of 48 SSc patients and ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00779-6

    authors: Li T,Ortiz-Fernández L,Andrés-León E,Ciudad L,Javierre BM,López-Isac E,Guillén-Del-Castillo A,Simeón-Aznar CP,Ballestar E,Martin J

    更新日期:2020-09-25 00:00:00

  • Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is the one of the most common cancers and lethal diseases in the world. DNA methylation alteration is frequently observed in HCC and may play important roles in carcinogenesis and diagnosis. METHODS:Using the TCGA HCC dataset, we classified HCC patients into different methylat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0548-z

    authors: Cheng J,Wei D,Ji Y,Chen L,Yang L,Li G,Wu L,Hou T,Xie L,Ding G,Li H,Li Y

    更新日期:2018-05-30 00:00:00

  • Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned.

    abstract::Candidate gene association studies, linkage studies and genome-wide association studies have highlighted the role of genetic factors in the development of ischemic stroke. This research started over a decade ago, and can be separated into three major periods of research. In the first wave classic susceptibility marker...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm185

    authors: Maasz A,Melegh B

    更新日期:2010-09-13 00:00:00

  • Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.

    abstract:BACKGROUND:Retinoid therapy is widely employed in clinical oncology to differentiate malignant cells into their more benign counterparts. However, certain high-risk cohorts, such as patients with MYCN-amplified neuroblastoma, are innately resistant to retinoid therapy. Therefore, we employed a precision medicine approa...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0407-3

    authors: Duffy DJ,Krstic A,Halasz M,Schwarzl T,Konietzny A,Iljin K,Higgins DG,Kolch W

    更新日期:2017-02-10 00:00:00

  • Back to the family: a renewed approach to rare variant studies.

    abstract::A report on the 62nd Annual Meeting of the American Society of Human Genetics, San Francisco, California, USA, 6-10 November 2012. ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm398

    authors: Zielinski D,Gymrek M,Erlich Y

    更新日期:2012-12-19 00:00:00

  • Use of semantic workflows to enhance transparency and reproducibility in clinical omics.

    abstract:BACKGROUND:Recent highly publicized cases of premature patient assignment into clinical trials, resulting from non-reproducible omics analyses, have prompted many to call for a more thorough examination of translational omics and highlighted the critical need for transparency and reproducibility to ensure patient safet...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0202-y

    authors: Zheng CL,Ratnakar V,Gil Y,McWeeney SK

    更新日期:2015-07-25 00:00:00

  • A population-based gene expression signature of molecular clock phase from a single epidermal sample.

    abstract:BACKGROUND:For circadian medicine to influence health, such as when to take a drug or undergo a procedure, a biomarker of molecular clock phase is required--one that is easily measured and generalizable across a broad population. It is not clear that any circadian biomarker yet satisfies these criteria. METHODS:We ana...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00768-9

    authors: Wu G,Ruben MD,Francey LJ,Smith DF,Sherrill JD,Oblong JE,Mills KJ,Hogenesch JB

    更新日期:2020-08-21 00:00:00

  • An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets.

    abstract::During COVID-19, diagnostic serological tools and vaccines have been developed. To inform control activities in a post-vaccine surveillance setting, we have developed an online "immuno-analytics" resource that combines epitope, sequence, protein and SARS-CoV-2 mutation analysis. SARS-CoV-2 spike and nucleocapsid prote...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00822-6

    authors: Ward D,Higgins M,Phelan JE,Hibberd ML,Campino S,Clark TG

    更新日期:2021-01-07 00:00:00

  • Personalizing carbamazepine therapy.

    abstract::The anticonvulsant carbamazepine has a high incidence of cutaneous adverse drug reactions. A recent prospective clinical trial in Taiwan has indicated that HLA-B*1502 screening will reduce the incidence of life-threatening adverse reactions to carbamazepine, while a genome-wide association study has identified the HLA...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm243

    authors: Mushiroda T,Nakamura Y

    更新日期:2011-05-30 00:00:00

  • The pan-cancer landscape of prognostic germline variants in 10,582 patients.

    abstract:BACKGROUND:While clinical factors such as age, grade, stage, and histological subtype provide physicians with information about patient prognosis, genomic data can further improve these predictions. Previous studies have shown that germline variants in known cancer driver genes are predictive of patient outcome, but no...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-0718-7

    authors: Chatrath A,Przanowska R,Kiran S,Su Z,Saha S,Wilson B,Tsunematsu T,Ahn JH,Lee KY,Paulsen T,Sobierajska E,Kiran M,Tang X,Li T,Kumar P,Ratan A,Dutta A

    更新日期:2020-02-17 00:00:00

  • An epigenome-wide association study of sex-specific chronological ageing.

    abstract:BACKGROUND:Advanced age is associated with cognitive and physical decline and is a major risk factor for a multitude of disorders. There is also a gap in life expectancy between males and females. DNA methylation differences have been shown to be associated with both age and sex. Here, we investigate age-by-sex differe...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0693-z

    authors: McCartney DL,Zhang F,Hillary RF,Zhang Q,Stevenson AJ,Walker RM,Bermingham ML,Boutin T,Morris SW,Campbell A,Murray AD,Whalley HC,Porteous DJ,Hayward C,Evans KL,Chandra T,Deary IJ,McIntosh AM,Yang J,Visscher PM,McRa

    更新日期:2019-12-31 00:00:00

  • Best practices for bioinformatic characterization of neoantigens for clinical utility.

    abstract::Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tumor-specific T cell recognition. Recently, researchers and clinicians have leveraged next generation sequencing technologies to identify neoantigens and to create personalized immunotherapies for cancer treatment. To cr...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-019-0666-2

    authors: Richters MM,Xia H,Campbell KM,Gillanders WE,Griffith OL,Griffith M

    更新日期:2019-08-28 00:00:00

  • Stem cell banking: between traceability and identifiability.

    abstract::Stem cell banks are increasingly seen as an essential resource of biological materials for both basic and translational research. Stem cell banks support transnational access to quality-controlled and ethically sourced stem cell lines from different origins and of varying grades. According to the Organisation for Econ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm194

    authors: Knoppers BM,Isasi R

    更新日期:2010-10-05 00:00:00